Cargando…

Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer

Patients with metastatic breast cancer involving the liver and brain often have short overall survival. Here, we report a case of de novo metastatic breast cancer with multiple liver metastases at initial diagnosis in February 2011 in a 35-year-old Caucasian female patient. The histology was poorly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieder, Carsten, Mannsåker, Bård, Haukland, Ellinor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574629/ https://www.ncbi.nlm.nih.gov/pubmed/28856077 http://dx.doi.org/10.7759/cureus.1412

Ejemplares similares

Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
por: Nieder, Carsten, et al.
Publicado: (2022)

Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019)

Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance
por: Nieder, Carsten, et al.
Publicado: (2017)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
por: Nieder, Carsten, et al.
Publicado: (2023)

Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors
por: Nieder, Carsten, et al.
Publicado: (2023)

The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison
por: Nieder, Carsten, et al.
Publicado: (2015)

30-day mortality in patients treated for brain metastases: extracranial causes dominate
por: Nieder, Carsten, et al.
Publicado: (2022)

A Case of Five-Year Survival After Combined-Modality Treatment for Non-Small Cell Lung Cancer With Intraspinal Metastasis
por: Nieder, Carsten, et al.
Publicado: (2022)

Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
por: Nieder, Carsten, et al.
Publicado: (2022)

Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome
por: Nieder, Carsten, et al.
Publicado: (2020)

Second Re-irradiation: Clinical Examples of Worthwhile Treatment
por: Nieder, Carsten, et al.
Publicado: (2018)

Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery
por: Nieder, Carsten, et al.
Publicado: (2018)

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022)

Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
por: Nieder, Carsten, et al.
Publicado: (2020)

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?
por: Nieder, Carsten, et al.
Publicado: (2019)

Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)
por: Dalhaug, Astrid, et al.
Publicado: (2010)

Palliative Thoracic Radiotherapy for Non-Small Cell Lung Cancer in Outpatients: Reasons for Unplanned Hospitalization and Its Impact on Survival
por: Nieder, Carsten, et al.
Publicado: (2021)

The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2021)

Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2023)

Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Percent of remaining life on palliative radiation treatment: solely a function of fractionation?
por: Nieder, Carsten, et al.
Publicado: (2023)

Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
por: Nieder, Carsten, et al.
Publicado: (2022)

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
por: Ballinger, Tarah J., et al.
Publicado: (2018)

Exceptional Response to Systemic Therapy in Advanced Metastatic Gastric Cancer: A Case Report
por: Colton, Bradley, et al.
Publicado: (2016)

Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care
por: Haukland, Ellinor Christin, et al.
Publicado: (2020)

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013)

Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
por: Nieder, Carsten, et al.
Publicado: (2014)

Review of the status of neoadjuvant therapy in HER2-positive breast cancer
por: Dowling, Gavin P., et al.
Publicado: (2023)

Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
por: Angelo, Kent, et al.
Publicado: (2014)

Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2021)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer
por: Kaufman, Peter A., et al.
Publicado: (2023)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r1eo2md28qmlc10ua9126m51i7